, Tracking Stock Market Picks
Enter Symbol:
Amgen Inc. (AMGN) [hlAlert]

Equal Weight
up 41.87 %

Amgen Inc. (AMGN) rated Equal Weight with price target $130 by Barclays

Posted on: Friday,  Mar 21, 2014  1:25 PM ET by Barclays

Barclays rated Equal Weight Amgen Inc. (NASDAQ: AMGN) on 03/21/2014. Previously Barclays rated Overweight Amgen Inc. (NASDAQ: AMGN) on 08/27/2013.,
when the stock price was $109.76. Since then, Amgen Inc. has gained 41.87% as of 08/27/2015's recent price of $155.72.
If you would have followed the previous Barclays's recommendation on AMGN, you would have gained 41.87% of your investment in 730 days.

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/21/2014 1:25 PM Buy
123.82 130.00
as of 10/17/2014
1 Week down  -2.69 %
1 Month down  -4.98 %
3 Months up  15.85 %
1 YTD up  17.18 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/27/2013 12:25 PM Buy
109.76 115.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy